亚洲无线乱码高清在线观看一区,色一级,精品伊人久久,2018国产大陆天天弄,狠狠操夜夜爱,欧美日韩中文字幕在线,日本人视频网站一

首頁 /藥靶模型 /藥靶細胞 /免疫治療 /PDL2/CHO

PDL2/CHO

CBP74064

詢 價
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. Background
The binding of Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T-cells, to its ligands, PD-L1 and PD-L2, negatively regulates immune responses. The PD-1 ligands are found on most cancers, and PD-1:PD-L1/2 interaction inhibits T cell activity and allows cancer cells to escape immune surveillance.
 
II. Description
The PD-1:PD-L1/2 pathway is also involved in regulating autoimmune responses, making these proteins promising therapeutic targets for a number of cancers, as well as multiple sclerosis, arthritis, lupus, and type I diabetes.
 
III. Introduction
Host Cell: CHO
Expressed gene: PDL2
Stability: 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Synonym(s): Programmed Cell Death 2 Ligand 2, PDL2, PD-L2, CD273, PDCDL1G2, B7-DC
Freeze Medium: 90% FBS+10% DMSO
Culture Medium: F12K+10%FBS+500ug/ml hygromycin
Mycoplasma Testing: Negative
Storage: Liquid nitrogen
Application(s): Binding Assay,FACS
 
IV. Description of Host Cell Line
Organism: Cricetulus griseus, hamster, Chinese
Tissue: Ovary
Disease: Hamster Chinese ovary
Morphology: Epitheloid cell
Growth Properties: Adherent
 
Ⅴ. Representative Data

Figure 1. Recombinant CHO cells constitutively expressing human PD-L2.

 

藥靶模型聯(lián)系方式: 華東銷售經(jīng)理:18240630236 全國銷售經(jīng)理:18066071954
診斷標準品聯(lián)系方式: 華東銷售經(jīng)理:15000320447 華北銷售經(jīng)理:18131625521 華南銷售經(jīng)理:13484295986 華中&西南銷售經(jīng)理:13871580511 全國銷售經(jīng)理:13484295986

掃二維碼

立即提交